Opening book details…
About this book
Efficacy, safety, and target engagement of dazukibart, an IFNÃŽ2 specific monoclonal antibody, in adults with dermatomyositis: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial by Prof David Fiorentino MD PhD & Aaron R Mangold MD & Prof Victoria P Werth MD & Prof Lisa Christopher-Stine MD & Alisa Femia MD & Myron Chu DO & Prof Amy C M Musiek MD & Jason C Sluzevich MD & Lauren V Graham MD & Anthony P Fernandez MD & Prof Rohit... is a book available to read on EtoBox.
- Author
- Prof David Fiorentino MD PhD & Aaron R Mangold MD & Prof Victoria P Werth MD & Prof Lisa Christopher-Stine MD & Alisa Femia MD & Myron Chu DO & Prof Amy C M Musiek MD & Jason C Sluzevich MD & Lauren V Graham MD & Anthony P Fernandez MD & Prof Rohit...
- Publisher
- x
- Published
- 2025
- Language
- EN
More by Prof David Fiorentino MD PhD & Aaron R Mangold MD & Prof Victoria P Werth MD & Prof Lisa Christopher-Stine MD & Alisa Femia MD & Myron Chu DO & Prof Amy C M Musiek MD & Jason C Sluzevich MD & Lauren V Graham MD & Anthony P Fernandez MD & Prof Rohit...
Similar books
- Efficacy and Safety of Monoclonal Antibody PEP for Rabies — Corine H GeurtsvanKessel & Leo G Visser (2025)
- Efficacy and Safety of Low-dose IL-2 as an Add-on Therapy to Riluzole (MIROCALS): a Phase 2b, Double-blind, Randomised, Placebo-controlled Trial — Gilbert Bensimon PhD & Prof P Nigel Leigh PhD & Prof Timothy Tree PhD & Prof Andrea Malaspina PhD & Christine AM Payan MD & Hang-Phuong Pham PhD & Pieter Klaassen PGCert & Prof Pamela J Shaw MD & Ahmad Al Khleifat PhD & Maria D M Amador MD & Prof... (2025)
- Chikungunya Virus Virus-like Particle Vaccine Safety and Immunogenicity in Adults Older Than 65 Years: a Phase 3, Randomised, Double-blind, Placebo-controlled Trial — Lauren C Tindale PhD & Jason S Richardson PhD & Deborah M Anderson MS & Jason Mendy MS & Sufia Muhammad MD & Tobi Loreth BA & Sarah Royalty Tredo MBA & Roshan Ramanathan MD MPH & Victoria A Jenkins PhD & Lisa Bedell MA & Patrick Ajiboye MD &... (2025)
- Durability and Efficacy of Solbinsiran, a GalNAc-conjugated siRNA Targeting ANGPTL3, in Adults with Mixed Dyslipidaemia (PROLONG-ANG3): Double-blind, Randomised, Placebo-controlled, Phase 2 Trial — Prof Kausik K Ray FMedSci & Ena Oru MD & Robert S Rosenson MD & Jeremiah Jones PhD & Xiaosu Ma PhD & Jennie Walgren PhD & Axel Haupt MD & Subodh Verma MD & Daniel Gaudet MD & Prof Stephen J Nicholls MD & Giacomo Ruotolo MD (2025)
- Efficacy and Safety of Nerinetide in Acute Ischaemic Stroke in Patients Undergoing Endovascular Thrombectomy Without Previous Thrombolysis (ESCAPE-NEXT): a Multicentre, Double-blind, Randomised Controlled Trial — Prof Michael D Hill MD & Prof Mayank Goyal PhD & Prof Andrew M Demchuk MD & Prof Bijoy K Menon MD & Thalia S Field MD & William C Guest PhD & Prof Jorg Berrouschot MD & Albrecht Bormann MD & Prof Mirko Pham MD & Karl G Haeusler MD & Prof Diedrick W J... (2025)
- Safety and Efficacy of Once-weekly Efruxifermin Versus Placebo in Metabolic Dysfunction-associated Steatohepatitis (HARMONY): 96-week Results from a Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 2b Trial — Prof Mazen Noureddin MD & Juan P Frias MD & Guy W Neff MD & K Jean Lucas MD & Cynthia Behling MD & Pierre Bedossa MD & Julie Dubourg MD & Doreen Chan PhD & Mark Burch PhD & Erica Fong BS & Brittany de Temple BS & Matt Minerva BS & Kim Barrett BS &... (2025)